chrisvoncsefalvay/vaers-outcomes huggingface dataset:
soreness in the arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in the arm) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (soreness in the arm) and FATIGUE (fatigue) outcome was unknown.            Concomitant medication was not reported. Treatment medication was not reported.    This case was linked to MOD-2021-029671, MOD-2021-038923, MOD-2021-038496, MOD-2021-038840 (E2B Linked Report).
First Dose: On Monday the 21st I started getting a Fever and not feeling good. I found out that day my boss was home with Covid.  I did a Saliva test (covid test), while waiting for my test above my collar bone was swollen.  I was generally not feeling well. I got my results on the 25th and it was negative. On the 30th I got heart fluttering, feelin racy. It went away. On the 1st, I felt so wiped out and heart was going nuts, and I went to get a EKG that was normal but my BP was  high140/high 80. On the 4th I went back to work again and still felt horrible, dizzy and they sent me to the ER and had High BP and two normal EKG', and the hooked me up to a heart monitor for a week.  With both shots I had insomnia of the walls.   Second Dose: it was much better than 1st dose.  The Monday after the 2nd dose I got a really bad headache. I drank some Pedialyte and took a 12 hour nap and felt great after.
This case was reported by a physician via sales rep and described the occurrence of generalized muscle aches in a female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced generalized muscle aches, swelling and vomiting. On an unknown date, the outcome of the generalized muscle aches, swelling and vomiting were unknown. It was unknown if the reporter considered the generalized muscle aches, swelling and vomiting to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient felt a possibility of having a vomiting episode.
pain disappears the first vaccine hurt me more the second; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain (1st dose received on an unknown date, refer case US2023AMR082918).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: pain disappears the first vaccine hurt me more the second). Rechallenge with Shingles vaccine was positive. The outcome of the pain was resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     It was unknown if the company considered the pain to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR082918   Additional Information: GSK Receipt Date: 09-JUN-2023 This case was reported by the patient via interactive digital media. The patient stated that the first vaccine hurt more than the second and almost not but if it hurts a lot. The patient stated that put patches of warm water and everything would be fine. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR082918:Same patient
developed intercostal pain 3 hours after receiving the shingles vaccine; This case was reported by a consumer via call center representative and described the occurrence of intercostal pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 3 hrs after receiving Shingrix, the patient experienced intercostal pain. On an unknown date, the outcome of the intercostal pain was unknown.   It was unknown if the reporter considered the intercostal pain to be related to Shingrix.  Additional details were reported as follows: The age group was not reported but was selected as adult as per vaccine indication. The patient received Shingrix and after 3 hours developed intercostal pain.
Initial symptoms began about 8 hours after injection.  Body aches, chills/sweats, headache, fatigue.  Lasted approximately 24 hours.  No treatment sought.
I'm a 77 year old Male, I take no Meds. I do have Peripheral Neuropathy, I'm not a Diabetic. About 20-25 minutes after my shot on driving home my left leg started to go numb, time I got home both were feeling the same numbness. [takes about 15 minutes to get home] Here it is 4 days later still have the numbness, but not as bad.  Then on 2/13 Saturday evening I was watching TV, my eyes I started to see colors floating around in them. About 20-25 minutes later it was gone. The biggest thing with my feet and is it OK to go with the second shot?
lightheaded, "feels weird to swallow". Evaluated by EMS- Refusal to Transport.
Pfizer-BIONTECH COVID 19 VACINE EUA 1. MUSCLE PAIN MAKES IT DIFFICULT TO MOVE AROUND 2. JOINT PAIN IN KNEES AND HIPS causes slip and fall issues
5 hours after injection: Headache, Neck Stiffness, Low Back Pain, & Very tired.  An hour later my symptoms increased:  Fever of 101.6 which lasted for 3 hours.  Chills, Shivering, Exhaustion. Nausea.  After my fever broke, my Legs started Kicking involuntarily,.  They kicked Constantly for 2 hours. (It was scary and out of the ordinary.) So much so that my knees hurt.  If I forced my lag to stop kicking, my ankles and feet start jittering. If I get up to walk around my feet swell up.  I was Still nauseous.  I was unable to eat Lunch or Dinner. At bed time I was able to eat a bowl of cereal, and my legs finally stopped kicking. Nausea subsided. Next morning felt achy and had a runny nose. 34 hours after vaccination. felt tired, had chills and nausea again. I had to take a nap. The following day I felt like I was back to normal.
had been given Twinrix patient is currently 15 years old; This case was reported by a other health professional via representative and described the occurrence of inappropriate age at vaccine administration in a 15-year-old female patient who received HAB (Twinrix) (batch number 75C72, expiry date 13th June 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd August 2021, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 23rd August 2021, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. The action taken with Twinrix Pre-Filled Syringe Device was unknown. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as the reporter informed that, the patient had been given Twinrix and the patient was currently 15 years old at the time of reporting, which led to inappropriate age at vaccine administration.  The health care professional  mentioned they could help follow up with patient.  The reporter agreed to follow up, preferably by email.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a female subject of unspecified age who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medical conditions included blockage, heart attack and heart disease. On 2 October 2012 at 14:00 the subject received unspecified dose of FLULAVAL (. 5 ml, unknown, left arm) and experienced wrong vaccine administered. On 2 October 2012, within hours of vaccination with FLULAVAL, the subject experienced injection site redness, injection site warmth and injection site pruritus. The subject was supposed to have received a TB test and was given FLULAVAL in the forearm by mistake. The area of redness is the size of the palm of a hand with irregular borders. The area has become larger since it first presented but it is no raised just discolored. At the time of reporting the injection site redness and injection site warmth were unresolved; injection site pruritus had improved. Follow-up information was received on 30 October 2012 via healthcare professional who reported the events of injection site redness, injection site warmth and injection site pruritus were resolved.
Developed shingles starting 10/16 with  diagnosis 10/21. Red, inflamed skin on back with blisters and rash. Ongoing at this time
Body aches, chills, headache, extreme fatigue for approximately 48 hours.  Some body aches and fatigue continued for 10 more days.
flu-like symptoms; This is a spontaneous report from a Pfizer-sponsored program Support. A contactable consumer (patient herself) reported that a female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 2 via an unspecified route of administration on 25Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient historically received the first dose of BNT162B2 on an unspecified date for COVID-19 immunisation. On 25Feb2021, the patient experienced flu-like symptoms, overnight after she took the second dose of COVID-19 vaccine and wanted to know how long the said symptoms are going to last. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pink morbilliform mac-pap rash that started on face and progressed to trunk and upper/lower extremities. Rash started 10 days after MMRV vaccine placement.
child became dizzy and nauseated. He was sweating and tired.  He mentioned that his tongue felt weird but was normal on exam and no difficulty swallowing or breathing. Improved on laying down and drinking  fluids.
Severe shoulder pain. Can't raise arm above head. This has been going on for four months now.
Exhausting hiccups that last for up to an hour or more at a time, these symptoms are still ongoing; This spontaneous case was reported by a consumer and describes the occurrence of HICCUPS (Exhausting hiccups that last for up to an hour or more at a time, these symptoms are still ongoing) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced HICCUPS (Exhausting hiccups that last for up to an hour or more at a time, these symptoms are still ongoing). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form; HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) for Adverse event, at a dose of 1 dosage form; FAMOTIDINE (PEPCID [FAMOTIDINE]) for Muscle relaxant, at a dose of 1 dosage form and FENTANYL CITRATE (NARCO) for Adverse event, at an unspecified dose and frequency. At the time of the report, HICCUPS (Exhausting hiccups that last for up to an hour or more at a time, these symptoms are still ongoing) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Treatment medication updated.
12 Days later, Nausea, Vomiting, Cholecystitis. Hospitalized July 24, 2021.  Currently still hospitalized.   This may not be due to the COVID-19 vaccine BUT my Mother was fine prior to the shot and the proximity of her severe illness is very suspicious. Currently, she better but she is still hospitalized (6 days). She has never been in the hospital this longer than 2 days for tests and observation.  Because of her age Surgery is a risky option.    I am requesting research be done to discover others with Gastric issues after Pfizer's COVID-19 Vaccine.   I, personally,  another Pfizer COVID Vaccine recipient  with severe stomach pain since her Pfizer shot a few mos ago.   There's another friend (healthcare worker) who has been experiencing  a sense of malaise since her Moderna shot 3 mos ago.
8/29/19 3:45 PM Patient returned to HD to report reaction to vaccines received. Right Deltoid red area approximately 3.5cm diameter at injection site with larger hardened area approximately 4.5cm diameter. Left Deltoid has smaller reaction area with redness measuring approximately 0.5cm and hardened area approximately 1cm diameter at injection site. Patient states redness and swelling occurred overnight, but went to school today before coming to HD. Also c/o soreness and some itching. Right Deltoid is warm to touch. Mom of patient instructed to use ice packs, tylenol, and benadryl as needed for symptom relief. Instructed to call HD if any questions or worsening of symptoms or go to ER if has swelling in throat and/or difficulty with breathing.
Patient presented to Community Center at her scheduled appointment time to receive her  2nd dose of the COVID Pfizer vaccine. While being processed for 2nd dose vaccination, the client reported she experienced a feeling which she describes as a "a shot of adrenaline" about 5 minutes after administration of first Pfizer COVID vaccine.  RN responded. Client symptoms of elevated heart rate, shortness of breath and dizziness lasted 1-2 minutes and resolved without treatment. Client did not follow up with PCP.
SWOLLEN LYMPH NODES (2 IN THE NECK, 1 LEFT LOWER PART OF HEAD), HEADACHE
Pharmacist providing the immunization had a needle stick when attempting to close the needle cover safety device.
Severe nausea, pain at injection site, heat and swelling at injection site. Swollen lymph node left armpit High fever of 103.2 12/28/2021 Fever of 100 12/29/2021 Nerve pain right knee, leg wouldn't support standing 12/28/2021 Severe headache
The patient received a third pediatric dose of the Covid-19 vaccine. She received a first dose at a retail pharmacy on 11/26/2021. Then, came to the Vaccination Clinic and received pediatric doses on 12/18/2021 and 1/8/2022. I learned on 1/15/2022 that the dose administered on 1/8 was a third dose. According to her mother, both on 1/15/2022 and 1/17/2022, the child is doing fine with no adverse reactions or symptoms after receiving the third dose.
Fever, rash, dizziness, diarrhea, screaming much like he was experiencing encephalitis.
Redness and swelling to left deltoid 1 day after VARIVAX vaccine given.
Big lump on arm.  Extreme pain, cannot lift arm at all and pain is going up left side of shoulder and the left side of my neck. Forearm is numb, and the pain even seems to be in my shoulder bone (proper). This is the 3rd Anthrax shot I have had, and I do not remember ever feeling this.  The pain is the worst pain I have ever had with any immunization. Due to this, if I still feel the same in the a.m., I will have to miss work because I cannot even take my clothes off.  After immunization I did ensure that I maximized movement of my arm because the pain started within 20 seconds after immunization (burning and pain).  I thought movement would help disperse the shot.  This is 100 times worse than a Tetanus shot!
arm  is red around shot area. when she gave me shot at that time it was bleeding. she put a bandage. after two days i removed bandage.
Fever; discomfort at site of injection; pain in the injection area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 1, single (Batch/Lot number: unknown) at the age of 59 years for covid-19 immunisation. The patient's relevant medical history included: "lupus" (unspecified if ongoing); "fibromyalgia" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "Raynaud disease" (unspecified if ongoing); "cancer" (unspecified if ongoing); "allergic to Gluten" (unspecified if ongoing). Concomitant medication(s) included: AROMASIN. The following information was reported: PYREXIA (non-serious) with onset 2021, outcome "unknown", described as "Fever"; VACCINATION SITE DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "discomfort at site of injection"; VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "pain in the injection area". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Initial report received from a healthcare professional on 07 January 2014. A patient of unspecified demographics, whose medical history and concomitant medications were not reported, had received a dose of FLUZONE (intradermal, dose number, route, anatomical site of vaccination and batch number were not reported). On an unspecified date, the patient developed adverse event nos. Corrective treatments and laboratory investigations were not reported. As of this report, the outcome of the events was not reported. Documents held by sender: none.
Rash on arm at second dose subsided in week, unable to move arm to full capacity.   Period delayed by 2 weeks.   Ongoing heart palpitations and pain since.
minimal arm pain; This is a spontaneous report via a Pfizer-sponsored program Support from a contactable consumer (patient). This contactable consumer reported the same events for two patients (herself and her husband). This is the first of two reports.   A 66-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date (Batch/Lot number and expiry date were not reported) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient received the first dose of the Pfizer Covid 19 vaccine along with her 73-year-old husband on an unspecified date (reported as 'Tuesday night'. She reported minimal arm pain and only hurt when she touched it on an unspecified date. She wanted to know how long after dose two would potential side effects show up. She was considering rescheduling her second dose so she doesn't miss work. The outcome of the event was unknown. The event was reported as non-serious.   Information on the batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021185860 same reporter/drug/event, different patient
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 51-year-old male patient who received FLUARIX QUADRIVALENT (batch number 7DT2Y, expiry date 30th June 2016). Concomitant products included Losartan Hydrochlorothiazide Actavis and Valacyclovir. On 18th October 2015, the patient received FLUARIX QUADRIVALENT .5 ml. On 23rd October 2015, 5 days after receiving FLUARIX QUADRIVALENT, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. The reporter considered the injection site pain to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: This case was previously reported to a manufacturer. According to the reporter, the patient did not experience any redness, swelling or inflammation at the site of injection. The pain was rated as 8 out of 10 with 10 being the worst, which kept him away from sleeping and on a continuous basis. The reporter quickly wanted to get off the phone because she wanted to visit medical information department for further assistance. The reported batch number (TDT2Y) for FLUARIX QIV did not exist and was updated to 7DT2Y as per the sales database.
developed fever of 101.6 F; headache; ache in my left wrist, in left thumb and pointer finger.; This is a spontaneous report from a contactable consumer or other non hcp. A 46-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 16Mar2021 at the age of 46-years-old as DOSE 2, SINGLE for covid-19 immunization.The patient medical history was not reported. Patient took first dose of bnt162b2 (COMIRNATY, Solution for injection, Lot number was not reported) on 23FEB2021for Covid-19 immunization.The patient's concomitant medications were not reported.On 17Mar2021 the patient experienced developed fever of 101.6 f , headache, ache in my left wrist, in left thumb and pointer finger. The patient underwent lab tests and procedures which included body temperature: 101.6 fahrenheit on .Therapeutic measures were taken as a result of developed fever of 101.6 f , headache, ache in my left wrist, in left thumb and pointer finger. The outcome of event was unknown.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Information has been received from an RN and a 35 year old white female RN with no known drug allergies and a history of a miscarriage at 10 weeks on 5/25/01 who on 5/31/01 was vaccinated with MMRII. An RN in a physician's office reported that the pt was vaccinated with either lot 633092/0175K (expiration 1/02) or lot 636975/1281K (expiration 8/02); she was not sure which the pt received. Concomitant therapy included vitamins (unspecified). Prior therapy included globulin, immune (RHOGAM) on 5/25/01. The pt reported that on 6/22/01, she began to experience arthralgia of her wrists, hands, feet, ankles and knees, for which she sought medical attention. On 7/6/01, the pt's physician prescribed methylprednisolone (Medrol Dosepak), which was followed by therapy with decreasing doses of prednisone. Follow-up information has been received and indicated that the pt suffered from severe symmetrical polyarthritis. The symptoms resolved within 2 to 3 weeks of treatment with prednisone. No further information is available.
Hospitalized for positive COVID 19 with hypoxia, fever, fatigue, chills, rigors.
I felt dizzy and light headed. Then my body felt very heavy and I passed out. I woke up in the ground and my mom and brother put a wet rag on my forehead. I felt faint for 30 minutes afterwards.